Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News ANI Pharmaceuticals Inc ANIP

Healthcare
ANI Pharmaceuticals, Inc. is a diversified biopharmaceutical company, which serves patients in need by developing, manufacturing and marketing branded and generic prescription pharmaceutical products, including for diseases with high unmet medical need. The Company is focused on delivering sustainable growth by scaling up its Rare Disease business through its lead asset, Purified Cortrophin Gel... see more

Recent & Breaking News (NDAQ:ANIP)

ANI Pharmaceuticals Reports Record Third Quarter Results and Year-To-Date 2016 Highlights and Narrows Full-year Guidance

PR Newswire November 3, 2016

ANI Pharmaceuticals Schedules Conference Call to Discuss Third Quarter and Year-to-Date 2016 Financial Results

PR Newswire October 27, 2016

ANI Pharmaceuticals Announces Launch of Benztropine Mesylate Tablets USP

PR Newswire October 25, 2016

ANI Pharmaceuticals Announces Launch of Erythromycin Ethylsuccinate for Oral Suspension, 200mg/5mL

PR Newswire September 27, 2016

Benzinga's Volume Movers

Benzinga.com  July 19, 2016

IBM's Earnings Beat, Guidance Not Enough To Brighten Barclays' View Of The Stock

Benzinga.com  July 19, 2016

ANI Pharmaceuticals Gets FDA Approval And Immediate Launch Of Nilutamide Tablets

Benzinga.com  July 18, 2016

ANI Pharmaceuticals Announces Launch of Hydroxyprogesterone Caproate Injection USP, 250mg/mL

PR Newswire June 28, 2016

ANI Pharmaceuticals Gets FDA Approval For Oxcarbazepine Tablets

Benzinga.com  June 13, 2016

Bloomberg: European Stocks Could Plunge Around 25% Under A Yes 'Brexit' Vote Outcome

Benzinga.com  June 13, 2016

ANI Pharmaceuticals Announces FDA Approval of Oxcarbazepine Tablets

PR Newswire June 13, 2016

ANI Pharmaceuticals Announces Launch of Oxycodone Capsules, 5mg

PR Newswire June 13, 2016

ANI Announces Appointment of Mark J. Ginski Ph.D as Vice President Corticotropin Product Development

PR Newswire May 23, 2016

Credit Suisse Announces Coupon Payment on its Credit Suisse X-Links Cushing® MLP Infrastructure ETN (ticker symbol "MLPN").

PR Newswire May 23, 2016

ANI Pharmaceuticals to Present at the UBS Global Healthcare Conference

PR Newswire May 18, 2016

ANI Pharmaceuticals Enters Into Exclusive Distribution and Supply Agreement for Hydroxyprogesterone Caproate Injection USP

PR Newswire May 17, 2016

ANI Pharmaceuticals Launches Authorized Generic of Rowasa® Enema 4g/60mL

PR Newswire May 16, 2016

ANI Pharmaceuticals Enters Three Year $30 Million Asset Based Line of Credit with Citizens Bank

PR Newswire May 13, 2016

ANI Pharmaceuticals Announces Launch of 50mg and 150mg Fenofibrate Capsules in ANI label

PR Newswire May 9, 2016

ANI Pharmaceuticals Reports First Quarter Results and Year-To-Date 2016 Highlights and Reaffirms Updated Guidance

PR Newswire May 5, 2016